The FDA has Approved Bozutinib for Children with Chronic Myelogenous Leukemia

QR Code

The FDA has Approved Bozutinib for Children with Chronic Myelogenous Leukemia

.

Saved in:

Bibliographic Details
Main Author:	article Editorial
Format:	Article
Language:	Russian
Published:	Union of pediatricians of Russia 2023-11-01
Series:	Педиатрическая фармакология
Online Access:	https://www.pedpharma.ru/jour/article/view/2365
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The FDA has approved a new drug for the treatment of leukemia
by: article editorial
Published: (2024-12-01)

FDA HAS APPROVED THE FIRST THERAPY FOR NEUROENDOCRINE TUMORS IN CHILDREN
by: article Editorial
Published: (2024-07-01)

FDA HAS APPROVED NEW DRUG TREATMENT FOR HIV IN CHILDREN
by: article Editorial
Published: (2024-05-01)

FDA Has Approved Evolocumab for Theatment of Familial Hypercholesterolemia in Children
by: article Editorial
Published: (2021-12-01)

The FDA has approved the first treatment for Friedreich's ataxia
by: article Editorial
Published: (2023-05-01)

FDA Has Approved First Long-Acting Growth Hormone Preparation for Children
by: article Editorial
Published: (2021-12-01)

THE FDA HAS APPROVED A NEW ANTIBIOTIC FOR THE TREATMENT OF UTIS
by: article Editorial
Published: (2025-05-01)

THE FDA HAS APPROVED THE TRIPLE COMBINATION TOPICAL ACNE REMEDY
by: article Editorial
Published: (2023-12-01)

FDA HAS APPROVED THE LIQUID ADHD MEDICATION (NOT A STIMULANT)
by: article Editorial
Published: (2024-07-01)

The FDA has approved the first medical drug for Rett syndrome
by: article Editorial
Published: (2023-05-01)

FDA Has Approved First Drug for Treatment of Congenital Athymia
by: article Editorial
Published: (2021-12-01)

THE FDA HAS APPROVED A NEW COMBINED MENINGOCOCCAL VACCINE
by: article Editorial
Published: (2025-05-01)

THE FDA HAS APPROVED DUPILUMAB FOR THE PEDIATRIC TREATMENT OF ESOPHAGEAL DISEASES
by: article Editorial
Published: (2024-02-01)

THE FDA HAS APPROVED THE FIRST VACCINE AGAINST THE CHIKUNGUNYA VIRUS
by: article Editorial
Published: (2023-12-01)

FDA HAS APPROVED THE FIRST MEDICATION FOR RARE IMMUNITY-RELATED DISEASES
by: article Editorial
Published: (2024-07-01)

THE FDA HAS APPROVED A NEW TREATMENT FOR HEMOPHILIA A OR B
by: Article Editorial
Published: (2024-11-01)

FDA HAS APPROVED NEW DRUG TREATMENT FOR DUCHENE MUSCULAR DYSTROPHY
by: article Editorial
Published: (2024-05-01)

THE FDA HAS APPROVED THE THE FIRST DRUG FOR THE CONGENITAL FORM OF THROMBOTIC THROMBOCYTOPENIC PURPURA
by: article Editorial
Published: (2023-12-01)

The FDA has approved the first gene therapy for the treatment of Duchennel's muscular dystrophy
by: article Editorial
Published: (2023-08-01)

The FDA has approved the first medical drug for the treatment of primary immunodeficiency APDS
by: article Editorial
Published: (2023-05-01)

THE FDA HAS APPROVED TWO GENE THERAPY DRUGS FOR THE TREATMENT OF SICKLE CELL ANEMIA
by: article Editorial
Published: (2024-02-01)

The FDA has approved a new drug for adolescents and adults with severe focal alopecia
by: article Editorial
Published: (2023-08-01)

THE FDA HAS APPROVED A DRUG AGAINST NIEMANN–PICK DISEASE, TYPE C
by: Article Editorial
Published: (2024-11-01)

FOR THE FIRST TIME, THE FDA HAS APPROVED A GEL FOR THE TREATMENT OF MOLLUSCUM CONTAGIOSUM AT HOME
by: article Editorial
Published: (2024-02-01)

FDA HAS APPROVED FIRST FCRN-BLOCKER FOR MYASTHENIA GRAVIS
Published: (2025-07-01)

THE FDA HAS APPROVED THE FIRST DRUG FOR PEOPLE WITH PRADER – WILLI SYNDROME IN MEMORY OF A COLLEAGUE
by: article Editorial
Published: (2025-05-01)

FDA approves belimumab for treatment of children with lupus nephritis
by: article Editorial
Published: (2022-10-01)

FDA HAS APPROVED NEW TREATMENT FOR CHILDREN WITH ANY HEPATITIS C VIRUS STRAINS
Published: (2020-04-01)

Chronic myelogenous leukemia: molecular monitoring in clinical practice
by: N. R. Ryabchikova, et al.
Published: (2014-07-01)

The FDA has approved a vaccine for the prevention of whooping cough in infants up to 2 months of life
by: article Editorial
Published: (2023-01-01)

FDA APPROVES NEW HEMOPHILIA DRUG
by: article Editorial
Published: (2025-02-01)

Prognosis and Survival in Acute Myelogenous Leukemia
by: Dawod, Muath, et al.
Published: (2012)

FDA approved injection drug against schizophrenia
by: article Editorial
Published: (2023-07-01)

Impact of non-coding RNAs on resistance to imatinib in chronic myelogenous leukemia
by: Fatemeh Ensafi Talemi, et al.
Published: (2025-01-01)

Treating the Elderly Patient with Acute Myelogenous Leukemia
by: Payandeh, Mehrdad, et al.
Published: (2012)

FDA APPROVED THE FIRST NASAL SPRAY WITH ADRENALINE TO ELIMINATE ANAPHYLAXIS
by: article Editorial
Published: (2024-09-01)

FDA APPROVED A NEW DRUG FOR THE TREATMENT OF ATOPIC DERMATITIS
by: article Editorial
Published: (2024-09-01)

Novel Targets in Myelogenous Leukemia: The Id Family of Proteins
by: Klarmann, Kimberly D., et al.
Published: (2011)

FDA HAS ASSIGNED RMAT STATUS TO RETT SYNDROME GENE THERAPY
by: article Editorial
Published: (2024-07-01)

Overview of drugs approved by the FDA in 2022
by: D. V. Kurkin, et al.
Published: (2023-11-01)